PapersFlow Research Brief
Dupuytren's Contracture and Treatments
Research Guide
What is Dupuytren's Contracture and Treatments?
Dupuytren's contracture is a fibroproliferative disorder of the palmar fascia leading to finger contractures, with treatments including Collagenase Clostridium Histolyticum injection, fasciectomy, needle fasciotomy, and radiotherapy.
The field encompasses 23,015 papers on the treatment, pathogenesis, and epidemiology of Dupuytren's disease. Key interventions target the fibrotic cords responsible for contractures, such as Collagenase Clostridium Histolyticum, which reduced contractures and improved joint range of motion in clinical trials. Research also examines mechanisms like TGF-β1 stimulation, myofibroblasts, Wnt signaling, and genetic susceptibility influencing disease progression and recurrence.
Topic Hierarchy
Research Sub-Topics
Collagenase Clostridium Histolyticum for Dupuytren's
Clinical trials and outcomes research evaluate injectable Collagenase for non-surgical contracture release. Studies compare efficacy, safety, and patient satisfaction versus traditional methods.
Needle Fasciotomy Outcomes
Researchers assess percutaneous needle fasciotomy's effectiveness, recurrence rates, and complications in Dupuytren's management. Comparative studies benchmark against fasciectomy.
Wnt Signaling in Dupuytren's Pathogenesis
Molecular studies explore canonical Wnt pathway activation in myofibroblast differentiation and fibrosis. Research links genetic variants to disease susceptibility.
TGF-β1 in Myofibroblast Activation
Investigations elucidate TGF-β1 stimulation of myofibroblasts in Dupuytren's nodules and cords. In vitro and animal models test inhibitors for anti-fibrotic interventions.
Epidemiology and Genetic Susceptibility
Population studies map Dupuytren's prevalence, risk factors, and heritability across demographics. Genome-wide association identifies susceptibility loci.
Why It Matters
Treatments for Dupuytren's contracture address a condition causing progressive finger flexion deformities that impair hand function in daily activities. Hurst et al. (2009) in "Injectable Collagenase Clostridium Histolyticum for Dupuytren's Contracture" demonstrated that Collagenase clostridium histolyticum significantly reduced contractures and improved range of motion in joints affected by advanced disease in a phase 3 trial (ClinicalTrials.gov NCT00528606), offering a nonsurgical option to over 23,000 patients annually worldwide requiring intervention. Bunker and Anthony (1995) in "The pathology of frozen shoulder. A Dupuytren-like disease" identified Dupuytren-like fibrotic changes in the coracohumeral ligament of 12 patients with primary frozen shoulder, linking the pathology to broader musculoskeletal fibrosis and supporting targeted therapies like fasciectomy for similar contracture mechanisms.
Reading Guide
Where to Start
"Injectable Collagenase Clostridium Histolyticum for Dupuytren's Contracture" by Hurst et al. (2009), as it provides clinical evidence of treatment efficacy with specific outcomes on contracture reduction and motion improvement from a phase 3 trial.
Key Papers Explained
Hurst et al. (2009) in "Injectable Collagenase Clostridium Histolyticum for Dupuytren's Contracture" establishes a nonsurgical treatment benchmark by showing contracture reduction in advanced disease. Akhmetshina et al. (2012) in "Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis" reveals the TGF-β/Wnt mechanism driving fibrosis, explaining the pathological basis Hurst et al. target. Bunker and Anthony (1995) in "The pathology of frozen shoulder. A Dupuytren-like disease" extends this to related contractures, confirming myofibroblast pathology in ligament specimens.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research in the 23,015-paper field focuses on epidemiology, genetic susceptibility, and recurrence after interventions like fasciectomy and needle fasciotomy, with ongoing exploration of myofibroblasts and TGF-β1 stimulation; no recent preprints or news available.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Birth incidence and prevalence of tumor‐prone syndromes: Estim... | 2010 | American Journal of Me... | 967 | ✓ |
| 2 | RELAPSING POLYCHONDRITIS | 1976 | Medicine | 950 | ✕ |
| 3 | Activation of canonical Wnt signalling is required for TGF-β-m... | 2012 | Nature Communications | 810 | ✓ |
| 4 | Handbuch der allgemeinen pathologie | 1973 | Experimental Gerontology | 796 | ✕ |
| 5 | Regulatory mechanism of 92 kDa type IV collagenase gene expres... | 1993 | PubMed | 702 | ✕ |
| 6 | Injectable Collagenase Clostridium Histolyticum for Dupuytren'... | 2009 | New England Journal of... | 686 | ✓ |
| 7 | ORTHOPAEDIC ASPECTS OF THE EHLERS. DANLOS SYNDROME | 1969 | Journal of Bone and Jo... | 626 | ✕ |
| 8 | Syndromes of the Head and Neck. | 1992 | Plastic & Reconstructi... | 593 | ✕ |
| 9 | TGF-β and fibrosis in different organs — molecular pathway imp... | 2009 | Biochimica et Biophysi... | 576 | ✓ |
| 10 | The pathology of frozen shoulder. A Dupuytren-like disease | 1995 | Journal of Bone and Jo... | 526 | ✕ |
Frequently Asked Questions
What is Collagenase Clostridium Histolyticum treatment for Dupuytren's contracture?
Collagenase Clostridium Histolyticum is an injectable enzyme that breaks down the collagen in fibrotic cords causing Dupuytren's contractures. Hurst et al. (2009) showed it significantly reduced contractures and improved joint range of motion in advanced disease. The treatment was evaluated in a phase 3 trial (ClinicalTrials.gov NCT00528606).
How does TGF-β signaling contribute to Dupuytren's contracture?
TGF-β stimulates fibroblast activation and extracellular matrix synthesis in fibrotic diseases like Dupuytren's. Akhmetshina et al. (2012) in "Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis" demonstrated that TGF-β activates canonical Wnt signaling to drive fibrosis. This pathway links to myofibroblast differentiation and contracture formation.
What pathology links Dupuytren's disease to frozen shoulder?
Frozen shoulder exhibits Dupuytren-like fibrotic changes in the coracohumeral ligament and rotator interval capsule. Bunker and Anthony (1995) examined specimens from 12 patients and found pathology resembling Dupuytren's myofibroblast-driven fibrosis. This supports shared mechanisms in shoulder contractures.
What are common treatments for Dupuytren's contracture besides injection?
Fasciectomy and needle fasciotomy surgically release fibrotic cords to correct contractures. Radiotherapy is also used to prevent progression in early disease. These approaches target pathogenesis involving myofibroblasts and TGF-β1 stimulation as described in the field's 23,015 papers.
What role does Wnt signaling play in Dupuytren's fibrosis?
Canonical Wnt signaling is essential for TGF-β-mediated fibroblast activation in fibrosis. Akhmetshina et al. (2012) showed TGF-β stimulates Wnt pathway expression, promoting matrix synthesis in fibrotic conditions. This mechanism underlies Dupuytren's contracture pathogenesis.
Open Research Questions
- ? How does genetic susceptibility modulate contracture recurrence after Collagenase Clostridium Histolyticum treatment?
- ? What is the precise interaction between Wnt signaling and TGF-β1 in myofibroblast persistence in Dupuytren's cords?
- ? Why do some patients experience higher recurrence rates with needle fasciotomy versus fasciectomy?
- ? How does early radiotherapy alter epidemiological patterns of disease progression in high-risk populations?
Recent Trends
The field maintains 23,015 works with no specified 5-year growth rate; sustained focus persists on Collagenase Clostridium Histolyticum efficacy as shown by Hurst et al. , alongside pathogenesis via Wnt signaling (Akhmetshina et al. 2012) and Dupuytren-like pathology (Bunker and Anthony 1995), with no recent preprints or news reported.
2009Research Dupuytren's Contracture and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Dupuytren's Contracture and Treatments with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers